Accession |
PRJCA026139 |
Title |
Efficacy of Lactiplantibacillus plantarum P9 in modulating chronic diarrhea symptoms in young Adults: a double-blind, randomized, placebo-controlled trial |
Relevance |
Medical |
Data types |
Metabolomics
|
Organisms |
Homo sapiens
|
Description |
This study evaluated the beneficial effects of administering Lactiplantibacillus plantarum P9 (P9) in chronic diarrhea. To explore the metabolic mechanisms associated with P9 alleviating diarrhea, we collected stool samples from patients to screen potential differential metabolites through non-targeted metabolomic analysis. |
Sample scope |
Multiisolate |
Release date |
2024-05-14 |
Grants |
Agency |
program |
Grant ID |
Grant title |
National Natural Science Foundation of China (NSFC)
|
|
U22A20540
|
|
the National Key R&D Program of China
|
|
2022YFD2100700
|
|
the earmarked fund
|
|
CARS36
|
|
|
Submitter |
Ni
Yang (crjzliuwenjun@163.com)
|
Organization |
Jiangzhong Pharmaceutical Co., Ltd. |
Submission date |
2024-05-14 |